Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 18 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

9 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3
9(50.0%)
Phase 2
6(33.3%)
Phase 1
3(16.7%)
18Total
Phase 3(9)
Phase 2(6)
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT07132437Phase 1Completed

Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect

Role: lead

NCT07120308Phase 2Completed

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

Role: lead

NCT06209281Phase 3Active Not Recruiting

A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Role: lead

NCT06209320Phase 3Active Not Recruiting

A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Role: lead

NCT06766357Phase 3Recruiting

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

Role: lead

NCT06942793Phase 3Not Yet Recruiting

A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients

Role: lead

NCT06948357Phase 2Recruiting

Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

Role: lead

NCT06209203Phase 2Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

Role: lead

NCT05461339Phase 3Active Not Recruiting

TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

Role: collaborator

NCT06213727Phase 2Completed

ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

Role: lead

NCT06212973Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients

Role: lead

NCT02617459Phase 3Completed

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

Role: lead

NCT04541888Phase 3Completed

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

Role: lead

NCT04228926Phase 2Unknown

Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects

Role: lead

NCT03967548Phase 1Completed

The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

Role: lead

NCT03676335Phase 2Completed

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye

Role: lead

NCT03615768Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris

Role: collaborator

NCT03662971Phase 1Completed

Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

Role: lead

All 18 trials loaded